This Week’s CGT News: New FDA Genome Editing Guidance  - Summary - MDSpire

This Week’s CGT News: New FDA Genome Editing Guidance 

Our latest roundup highlights tighter FDA expectations for genome editing safety, advances in CRISPR precision and delivery, and continued momentum for off-the-shelf CAR-T

  • April 20, 2026

  • 6 min

Share

Original Source(s)

This Week’s CGT News: New FDA Genome Editing Guidance 

  • April 20, 2026

Related Content

Case Report: Zoledronic acid-induced hyperprogression in oncology: a case study of RET-driven neuroendocrine carcinoma treated with Selpercatinib

Editorial: Autoantibodies in cancer: diagnostic, prognostic, and therapeutic potential

Quality of life, morbidity, mortality, and long-term prognosis after craniopharyngioma